Evidence supporting the use of: Serratiopeptidase
For the body system: Lymphatics

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Table of Contents

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Serratiopeptidase is a proteolytic enzyme originally isolated from the bacterium Serratia marcescens. It has been traditionally used in parts of Asia and Europe for its anti-inflammatory and fibrinolytic properties. Regarding the lymphatic system, the rationale for its use is based on its ability to reduce inflammation and edema, which are closely related to lymphatic function. Several small clinical studies and animal models have shown that serratiopeptidase can help decrease swelling and promote the resorption of fluids, particularly following trauma or surgery. This suggests a supportive role for the lymphatic system, mainly through decreasing lymphatic congestion.

However, the scientific evidence specifically connecting serratiopeptidase to enhanced lymphatic function or direct lymphatic support is limited. Most studies focus on its effects on post-surgical swelling, chronic venous insufficiency, or inflammatory disorders, with lymphatic improvement being a secondary or inferred benefit. The enzyme's ability to break down protein-based inflammatory mediators and fibrin deposits may indirectly assist lymphatic drainage, but robust clinical trials directly measuring lymphatic outcomes are lacking.

In summary, while there is some scientific basis for serratiopeptidase's use in conditions involving lymphatic congestion or edema, the evidence is moderate at best, and further targeted research is required to clarify its specific benefits for the lymphatic system.

More about serratiopeptidase
More about Lymphatics

Other body systems supported by serratiopeptidase

Bronchials
Joints
Lymphatics
Sinuses